Details for Patent: 11,559,501
Which drugs does patent 11,559,501 protect, and when does it expire?
Patent 11,559,501 protects XELSTRYM and is included in one NDA.
This patent has six patent family members in six countries.
Summary for Patent: 11,559,501
| Title: | Transdermal amphetamine compositions with low levels of carbamate |
| Abstract: | Described are methods for reducing the formation of amphetamine carbamate and amphetacarbamate in transdermal amphetamine compositions, compositions with low levels of amphetacarbamate, and methods using such compositions for transdermal delivery of amphetamine. |
| Inventor(s): | Atsushi Sonobe, Deboprosad Mondal, Naruhito Higo |
| Assignee: | Noven Pharmaceuticals Inc |
| Application Number: | US17/569,862 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Delivery; |
Drugs Protected by US Patent 11,559,501
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-001 | Mar 22, 2022 | RX | Yes | No | 11,559,501 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-002 | Mar 22, 2022 | RX | Yes | No | 11,559,501 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-003 | Mar 22, 2022 | RX | Yes | No | 11,559,501 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-004 | Mar 22, 2022 | RX | Yes | Yes | 11,559,501 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,559,501
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 124577 | ⤷ Start Trial | |||
| Canada | 3203041 | ⤷ Start Trial | |||
| China | 116997330 | ⤷ Start Trial | |||
| European Patent Office | 4274555 | ⤷ Start Trial | |||
| Taiwan | 202241397 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2022150430 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
